NCT03587909

Brief Summary

Phacoemulsification in eyes with a shallow anterior chamber (ACD \< 2.2mm) presents with problems of safe access to the cataract and increased vulnerability of the endothelium and a higher tendency of complications such as descemet's detachment and iris prolapse. A shallow anterior chamber is also responsible for the high incidence of glaucoma and postoperative complications after cataract surgery. Femtosecond assisted cataract surgery has made cataract surgery safer and more predictable. The effective phacoemulsification time and intra-operative manipulation is greatly reduced in FLACS. However phacoemulsification still remains the most widely performed cataract surgery around the world. Post-operative outcomes after phacoemulsification in patients having shallow anterior chamber have been extensively reported in literature over the years. There is no head to head comparison in terms of intraoperative performance and post-operative outcomes between FLACS and phacoemulsification in eyes with shallow anterior chamber. The aim is to compare the intra-operative performance and post-operative outcomes in eyes undergoing femtosecond laser assisted cataract surgery versus eyes undergoing phacoemulsification in eyes having shallow anterior chamber. The study will bring an understanding on the question: Do patients undergoing Femtosecond laser assisted cataract surgery behave differently from those undergoing phacoemulsification?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 16, 2018

Completed
Last Updated

July 16, 2018

Status Verified

July 1, 2018

Enrollment Period

11 months

First QC Date

June 11, 2018

Last Update Submit

July 3, 2018

Conditions

Keywords

FLACSPhacoShallow Anterior Chamber

Outcome Measures

Primary Outcomes (1)

  • Central Corneal Thickness

    Central Corneal Thickness

    Postoperative Day 1

Secondary Outcomes (2)

  • Anterior Chamber Inflammation

    Postoperative Day 1

  • Endothelial Cell Morphology

    Postoperative 6 months

Study Arms (2)

Phacoemulsification Cataract Surgery

ACTIVE COMPARATOR

Procedure / Surgery : Phacoemulsification Surgery

Procedure: Phacoemulsification Cataract SUrgery

Femtosecond Cataract Surgery

ACTIVE COMPARATOR

Procedure / SUrgery - Femtosecond Laser Cataract surgery

Procedure: Femtosecond Cataract Surgery

Interventions

Phacoemulsification in eyes with shallow anterior chamber (\<2.5mm depth)

Phacoemulsification Cataract Surgery

Femtosecond Cataract Surgery in eyes with shallow anterior chamber \< 2.5mm

Femtosecond Cataract Surgery

Eligibility Criteria

Age30 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • uncomplicated, age related cataracts
  • Shallow anterior chamber (measured as \</=2.5mm )

You may not qualify if:

  • Coexisting ocular morbidity,
  • inability to come for followup

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iladevi Cataract & IOL Research Center

Ahmedabad, Gujarat, 380052, India

Location

Study Officials

  • Abhay Vasavada, MS,FRCS

    Iladevi Cataract & IOL Research Centre, Ahmedabad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 11, 2018

First Posted

July 16, 2018

Study Start

January 1, 2017

Primary Completion

December 1, 2017

Study Completion

January 15, 2018

Last Updated

July 16, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations